Enrique Díaz de León González1, Hugo Gutiérrez Hermosillo2, Jesus Avilio Martinez Beltran3, Juan Humberto Medina Chavez4, Rebeca Palacios Corona5, Deborah Patricia Salinas Garza1, Karina Alejandra Rodriguez Quintanilla6. 1. Unidad Médica de Alta Especialidad, Hospital de Traumatología y Ortopedia No. 21, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. 2. Unidad Médica de Alta Especialidad, Centro Médico Nacional del Bajío, Hospital de Especialidades, Instituto Mexicano del Seguro Social, León, Guanajuato, Mexico. 3. Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 71, Instituto Mexicano del Seguro Social, Torreón, Coahuila, Mexico. 4. Coordinación Técnica de Excelencia Clínica, Coordinación de UMAE, Dirección de Prestaciones Médicas, Instituto Mexicano del Seguro Social, México, Distrito Federal, Mexico. 5. Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Mexico. 6. Unidad Médica de Alta Especialidad, Hospital de Traumatología y Ortopedia No. 21, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. drakarinardz@yahoo.com.
Abstract
BACKGROUND: The aging population in Latin America is characterized by not optimal conditions for good health, experiencing high burden of comorbidity, which contribute to increase the frequency of frailty; thus, identification should be a priority, to classify patients at high risk to develop its negative consequences. AIM: The objective of this analysis was to validate the FRAIL instrument to measure frailty in Mexican elderly population, from the database of the Mexican Health and Aging Study (MHAS). MATERIALS AND METHODS: Prospective, population study in Mexico, that included subjects of 60 years and older who were evaluated for the variables of frailty during the year 2001 (first wave of the study). Frailty was measured with the five-item FRAIL scale (fatigue, resistance, ambulation, illnesses, and weight loss). The robust, pre-frail or intermediate, and the frail group were considered when they had zero, one, and at least two components, respectively. Mortality, hospitalizations, falls, and functional dependency were evaluated during 2003 (second wave of the study). Relative risk was calculated for each complications, as well as hazard ratio (for mortality) through Cox regression model and odds ratio with logistic regression (for the rest of the outcomes), adjusted for covariates. RESULTS: The state of frailty was independently associated with mortality, hospitalizations, functional dependency, and falls. The pre-frailty state was only independently associated with hospitalizations, functional dependency, and falls. CONCLUSIONS: Frailty measured through the FRAIL scale, is associated with an increase in the rate of mortality, hospitalizations, dependency in activities of daily life, and falls.
BACKGROUND: The aging population in Latin America is characterized by not optimal conditions for good health, experiencing high burden of comorbidity, which contribute to increase the frequency of frailty; thus, identification should be a priority, to classify patients at high risk to develop its negative consequences. AIM: The objective of this analysis was to validate the FRAIL instrument to measure frailty in Mexican elderly population, from the database of the Mexican Health and Aging Study (MHAS). MATERIALS AND METHODS: Prospective, population study in Mexico, that included subjects of 60 years and older who were evaluated for the variables of frailty during the year 2001 (first wave of the study). Frailty was measured with the five-item FRAIL scale (fatigue, resistance, ambulation, illnesses, and weight loss). The robust, pre-frail or intermediate, and the frail group were considered when they had zero, one, and at least two components, respectively. Mortality, hospitalizations, falls, and functional dependency were evaluated during 2003 (second wave of the study). Relative risk was calculated for each complications, as well as hazard ratio (for mortality) through Cox regression model and odds ratio with logistic regression (for the rest of the outcomes), adjusted for covariates. RESULTS: The state of frailty was independently associated with mortality, hospitalizations, functional dependency, and falls. The pre-frailty state was only independently associated with hospitalizations, functional dependency, and falls. CONCLUSIONS: Frailty measured through the FRAIL scale, is associated with an increase in the rate of mortality, hospitalizations, dependency in activities of daily life, and falls.
Authors: Yuji Okura; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Richard J Rodeheffer Journal: J Clin Epidemiol Date: 2004-10 Impact factor: 6.437
Authors: Jeremy Walston; Evan C Hadley; Luigi Ferrucci; Jack M Guralnik; Anne B Newman; Stephanie A Studenski; William B Ershler; Tamara Harris; Linda P Fried Journal: J Am Geriatr Soc Date: 2006-06 Impact factor: 5.562
Authors: Olga Theou; Lynne Cann; Joanna Blodgett; Lindsay M K Wallace; Thomas D Brothers; Kenneth Rockwood Journal: Ageing Res Rev Date: 2015-04-04 Impact factor: 10.895
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Silvia Mejía-Arango; Alejandro Miguel-Jaimes; Antonio Villa; Liliana Ruiz-Arregui; Luis Miguel Gutiérrez-Robledo Journal: Salud Publica Mex Date: 2007
Authors: John E Morley; Bruno Vellas; G Abellan van Kan; Stefan D Anker; Juergen M Bauer; Roberto Bernabei; Matteo Cesari; W C Chumlea; Wolfram Doehner; Jonathan Evans; Linda P Fried; Jack M Guralnik; Paul R Katz; Theodore K Malmstrom; Roger J McCarter; Luis M Gutierrez Robledo; Ken Rockwood; Stephan von Haehling; Maurits F Vandewoude; Jeremy Walston Journal: J Am Med Dir Assoc Date: 2013-06 Impact factor: 4.669
Authors: José Juan García-González; Carmen García-Peña; Francisco Franco-Marina; Luis Miguel Gutiérrez-Robledo Journal: BMC Geriatr Date: 2009-11-03 Impact factor: 3.921
Authors: Kerri M Winters-Stone; Esther Moe; Julie N Graff; Nathan F Dieckmann; Sydnee Stoyles; Carolyn Borsch; Joshi J Alumkal; Christopher L Amling; Tomasz M Beer Journal: J Am Geriatr Soc Date: 2017-03-06 Impact factor: 5.562
Authors: Luis M Valderrama-Hinds; Soham Al Snih; Nai-Wei Chen; Martin A Rodriguez; Rebeca Wong Journal: Aging Clin Exp Res Date: 2018-04-17 Impact factor: 3.636
Authors: Anjali Sharma; Donald R Hoover; Qiuhu Shi; Deborah R Gustafson; Michael Plankey; Phyllis C Tien; Kathleen M Weber; David E Vance; Michelle Floris-Moore; Hector H Bolivar; Elizabeth T Golub; Marcia M Holstad; Michael T Yin Journal: J Acquir Immune Defic Syndr Date: 2021-06-01 Impact factor: 3.771
Authors: Jossiana Wilke Faller; David do Nascimento Pereira; Suzana de Souza; Fernando Kenji Nampo; Fabiana de Souza Orlandi; Silvia Matumoto Journal: PLoS One Date: 2019-04-29 Impact factor: 3.240
Authors: Fabiana Araújo Figueiredo Da Mata; Priscilla Perez da Silva Pereira; Keitty Regina Cordeiro de Andrade; Ana Claudia Morais Godoy Figueiredo; Marcus Tolentino Silva; Maurício Gomes Pereira Journal: PLoS One Date: 2016-08-08 Impact factor: 3.240
Authors: Reshma Aziz Merchant; Richard Jor Yeong Hui; Sing Cheer Kwek; Meena Sundram; Arthur Tay; Jerome Jayasundram; Matthew Zhixuan Chen; Shu Ee Ng; Li Feng Tan; John E Morley Journal: Front Med (Lausanne) Date: 2020-07-08
Authors: Peter Hanlon; Barbara I Nicholl; Bhautesh Dinesh Jani; Duncan Lee; Ross McQueenie; Frances S Mair Journal: Lancet Public Health Date: 2018-06-14